$43.57
▼ -0.0% Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Eton Pharmaceuticals (ETON) Moves 13.8% Higher: Will This Strength Last?
Canaccord Genuity Initiates Eton Pharmaceuticals at Buy With $60 Price Target
Eton Pharmaceuticals Insider Sold Shares Worth $1,623,795, According to a Recent SEC Filing
Overview
52-week range
$13
$36
100% of range
Avg surprise (last 3)
-324.1%
Avg reaction (last 2)
-2.2%
0% positive
Latest IV / EM
73%
EM ±16.8% · $45 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $0.05 | $0.10 | -50.0% | -28.6% | -2.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.07 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.10 | $-0.01 | -900.0% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $0.07 | $0.09 | -22.2% | — | -1.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.02 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.12 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.03 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.02 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.18 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | $0.13 | -$0.10 | +230.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24M | — | $22M | $19M | $17M | — | $10M | $9M |
| Cost of revenue | $10M | — | $15M | $7M | $7M | — | $4M | $3M |
| Gross profit | $15M | — | $8M | $12M | $10M | — | $6M | $6M |
| Operating income | $2M | — | $-1M | $-1M | $-470,000 | — | $509,000 | $-3M |
| Net income | $2M | — | $-2M | $-3M | $-2M | — | $627,000 | $-3M |
| EPS (diluted) | $0.05 | — | $-0.07 | — | $-0.06 | — | $0.02 | $-0.12 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $20M | $26M | $37M | $25M | $17M | $15M | $20M | $18M |
| Inventory | $14M | $15M | $17M | $24M | $14M | $15M | $2M | $2M |
| Total current assets | $53M | $61M | $72M | $68M | $50M | $41M | $30M | $25M |
| Total assets | $98M | $92M | $105M | $102M | $84M | $76M | $36M | $32M |
| Long-term debt | $19M | $22M | $28M | $27M | — | $30M | — | — |
| Total liabilities | $67M | $66M | $81M | $78M | $60M | $52M | $20M | $18M |
| Total equity | $31M | $26M | $23M | $24M | $24M | $24M | $16M | $13M |